Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Katrine Pagsberg

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Contemporary Clinical Trials|February 7, 2026
Early intervention versus treatment as usual for adolescents with first-episode psychosis: Protocol for the randomized OPUS YOUNG trialMathilde S Madsen, Marianne Melau, Naja K Andersen, et al.
Scientific Reports|November 20, 2024
The association between salivary oxytocin, age, and puberty in children with and without OCDAnna-Rosa Cecilie Mora-Jensen, Line Katrine Harder Clemmensen, Manja Gersholm Grønberg, et al.
The Lancet. Psychiatry|June 11, 2017
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trialAnne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, et al.
Trials|October 6, 2022
Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents (the TECTO trial): a statistical analysis plan for the randomised clinical trialMarkus Harboe Olsen, Julie Hagstrøm, Nicole Nadine Lønfeldt, et al.
Contemporary Clinical Trials Communications|July 27, 2023
Adverse events in cognitive behavioral therapy and relaxation training for children and adolescents with obsessive-compulsive disorder: A mixed methods study and analysis plan for the TECTO trialLinea Pretzmann, Sofie Heidenheim Christensen, Anne Bryde Christensen, et al.
BMC Psychiatry|July 13, 2014
Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trialAnne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2026
Child and adolescent psychiatry: challenges, solutions, opportunities, and future directionsSamuele Cortese, Celso Arango, Claudia Aymerich, et al.
Neuroscience and Biobehavioral Reviews|March 31, 2023
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indicationsSamuele Cortese, Katherine McGinn, Mikkel Højlund, et al.
European Child & Adolescent Psychiatry|July 31, 2025
Family-based cognitive behavioral therapy versus family-based psychoeducation and relaxation training for obsessive-compulsive disorder in children and adolescents: a randomized clinical trial (TECTO)Anne Katrine Pagsberg, Nicole Nadine Lønfeldt, Christine Lykke Thoustrup, et al.
The Lancet. Psychiatry|December 10, 2023
Psychopharmacology in children and adolescents: unmet needs and opportunitiesSamuele Cortese, Diane Purper-Ouakil, Alan Apter, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Contemporary Clinical Trials|February 7, 2026
Early intervention versus treatment as usual for adolescents with first-episode psychosis: Protocol for the randomized OPUS YOUNG trialMathilde S Madsen, Marianne Melau, Naja K Andersen, et al.
Scientific Reports|November 20, 2024
The association between salivary oxytocin, age, and puberty in children with and without OCDAnna-Rosa Cecilie Mora-Jensen, Line Katrine Harder Clemmensen, Manja Gersholm Grønberg, et al.
The Lancet. Psychiatry|June 11, 2017
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trialAnne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, et al.
Trials|October 6, 2022
Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents (the TECTO trial): a statistical analysis plan for the randomised clinical trialMarkus Harboe Olsen, Julie Hagstrøm, Nicole Nadine Lønfeldt, et al.
Contemporary Clinical Trials Communications|July 27, 2023
Adverse events in cognitive behavioral therapy and relaxation training for children and adolescents with obsessive-compulsive disorder: A mixed methods study and analysis plan for the TECTO trialLinea Pretzmann, Sofie Heidenheim Christensen, Anne Bryde Christensen, et al.
BMC Psychiatry|July 13, 2014
Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trialAnne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2026
Child and adolescent psychiatry: challenges, solutions, opportunities, and future directionsSamuele Cortese, Celso Arango, Claudia Aymerich, et al.
Neuroscience and Biobehavioral Reviews|March 31, 2023
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indicationsSamuele Cortese, Katherine McGinn, Mikkel Højlund, et al.
European Child & Adolescent Psychiatry|July 31, 2025
Family-based cognitive behavioral therapy versus family-based psychoeducation and relaxation training for obsessive-compulsive disorder in children and adolescents: a randomized clinical trial (TECTO)Anne Katrine Pagsberg, Nicole Nadine Lønfeldt, Christine Lykke Thoustrup, et al.
The Lancet. Psychiatry|December 10, 2023
Psychopharmacology in children and adolescents: unmet needs and opportunitiesSamuele Cortese, Diane Purper-Ouakil, Alan Apter, et al.
Pageof 11